Scharlab adds Columbia CNA Agar for Isolation of Gram +ve Cocci
go back to news archives Scharlab have added Columbia CNA Agar to their catalogue of culture media. Widely used medium in the clinical laboratory for the selective isolation of Gram-positive cocci with the addition of defibrinated blood to the formulation. This medium owes its selectivity to the presence of two antibiotics: nalidixic acid and colistin. The advantage which this Scharlau medium offers regular users is that these antibiotics are already incorporated in its formulation, and there are no further additions necessary in the form of supplements. Nalidixic acid inhibits Enterobacteriaceae in particular, whereas Pseudomonas is especially susceptible to colistin. The combination of these antibiotics is very effective in allowing the growth and haemolytic reactions of Staphylococci, Streptococci, Enterococci and yeasts. |
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : Scharlab,S.L. View Company Information
Posted on March 15, 2011
LATEST MICROBIOLOGY NEWS
-
AOAC Validated iQ-Check Vibrio PCR Kit
01 Apr 2025 -
AI-Powered Precision For Colony Counting
27 Mar 2025
MICROBIOLOGY EVENTS
-
Mycotoxin Detection and Analysis: Strategies to Support Your Testing Program
3 Apr 2025 -
15th Conference of The World Mycotoxin Forum® – WMFmeetsSalzburg
7 Apr 2025 -
ESCMID European Congress of Clinical Microbiology and Infectious Diseases
11 Apr 2025 -
IBQC 2025
14 Apr 2025 -
IFU Technical Workshop 2025
15 Apr 2025 -
Validation of Water Systems for Microbial Control
23 Apr 2025 -
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
Free Expert Webinar: Advancing Drinking Water Microbiology Testing Compliance & Efficiency
29 Apr 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025